A design matrix of specialised service providers focused on your needs
Our own network of specialised service-provider companies allows us to carry out projects in a way that offers the client the advantage of specialisation and the flexibility of a personalised service as well as the strength of a group with centralised project management. The result for the client is a combination of dedication and flexibility throughout the project.
Services
Our four areas of activity
Early Drug Discovery
- Target Identification & Validation
- Hit Discovery
- Assay Development & Screening
- High Throughput Screening
- Hit to Lead
- Lead Optimisation
Clinical Development
- Phase I – Healthy Volunteer Study
- Phase II and Phase III – Studies in Patient Populations
- Dose Escalation, Single Ascending & Multiple Dose Studies
- Safety & Efficiancy
- Pharmacokinetic Analysis
- Bionanalytical Method Development & Validation
- Marketing & Health Economics
Preclinical Studies
- In Vivo, In Vitro & Ex Vivo Assays
- ADME
- Proof of Concept
- Drug Delivery
- Formulation Optimisation & Bioavailability
- Dose Range Finding
- IND-enabling Studies
- IND Application
Regulatory & Registration
- Regulatory Strategy
- Scientific Advice
- Clinical Protocol Design
- Orphan Drug Applications
- Regulatory and Medical Writing
- Development of Investigationals Medicinal Product Dossier (IMPD)
- Paediatric Investigation Plan (PIP)
- Regulatory Submission Management